Early Modeled Longitudinal CA-125 Kinetics and Survival of Ovarian Cancer Patients: A GINECO AGO MRC CTU Study-Reference-Cited by-同舟云学术

Early Modeled Longitudinal CA-125 Kinetics and Survival of Ovarian Cancer Patients: A GINECO AGO MRC CTU Study

Published:2019-04-01 Issue:17 Volume:25 Page:5342-5350
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Colomban Olivier,Tod Michel,Leary Alexandra^ORCID,Ray-Coquard Isabelle,Lortholary Alain,Hardy-Bessard Anne Claire,Pfisterer Jacobus,Du Bois Andreas^ORCID,Kurzeder Christian^ORCID,Burges Alexander^ORCID,Péron Julien^ORCID,Freyer Gilles,You Benoit

Funder

Hospices Civils de LyonHospices Civils de Lyon (HCL)

ARCAGY-GINECO

ArbeitGemeinschaft Gynakologische Onkologie

Gynecologic Cancer Intergroup

MRC Clinical Trial Unit at UCL

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Model-informed precision dosing: State of the art and future perspectives;Advanced Drug Delivery Reviews;2024-08

2. Prognostic Role of CA-125 Elimination Rate Constant (KELIM) in Patients with Advanced Epithelial Ovarian Cancer Who Received PARP Inhibitors;Cancers;2024-06-26

3. The serum LDH level and KELIM scores are potential predictors of a benefit from bevacizumab first-line therapy for patients with advanced ovarian cancer;Clinical and Translational Oncology;2024-06-21

4. KELIM score predicts outcome in patients with platinum-resistant/refractory recurrent ovarian cancer;Biomarkers in Medicine;2024-06-17

5. Clinical value of serum tumor markers in assessing the efficacy of neoadjuvant chemotherapy in advanced ovarian cancer: single-center prospective clinical study;Frontiers in Oncology;2024-05-28